Medications that stimulate the CYP system can predispose patients to APAP hepatotoxicity by causing enhanced production of NAPQI via the oxidative pathway.25 Case series reports have concluded that in 50% of adult patients with APAP-induced acute liver failure, the life-threatening condition was preceded by ingestion of potentially hepatotoxic herbs within 8 weeks of hospital presentation.4 The prescription agents known for their hepatotoxic tendencies include anti-epileptic drugs, such as phenobarbital, phenytoin and carbamazepine, as well as anti-tuberculosis drugs, such as isoniazid and rifampin
Both NAFLD and NASH have been studied as potential targets for silymarin therapy in the future (Handayani & Prijanti, 2024
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a fragment of human gastric juice protein, supplied as a 10mg lyophilised powder vial for in vitro research use
Patients who specifically want FDA-approved branded products will need to explore other telehealth platforms or traditional healthcare providers
Thats part of the problem, says Henry Ellis, a sports medicine surgeon and researcher at the University of Texas, Southwestern, in Dallas, Texas, who has written about BPC-157 for the American Orthopedic Society for Sports Medicine (AOSSM)
BPC-157: angiogenesis + NO + gastroprotection + neuroprotection